Boron neutron capture therapy (BNCT): A unique role in radiotherapy with a view to entering the accelerator-based BNCT era

M Suzuki - International journal of clinical oncology, 2020 - Springer
Boron neutron capture therapy (BNCT) has a unique property of tumor-cell-selective heavy-
particle irradiation. BNCT can form large dose gradients between cancer cells and normal …

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

RF Barth, MG H Vicente, OK Harling, WS Kiger… - Radiation …, 2012 - Springer
Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on
the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is …

Boron neutron capture therapy: Current status and challenges

S Wang, Z Zhang, L Miao, Y Li - Frontiers in Oncology, 2022 - frontiersin.org
Boron neutron capture therapy (BNCT) is a re-emerging therapy with the ability to selectively
kill tumor cells. After the boron delivery agents enter the tumor tissue and enrich the tumor …

Boron neutron capture therapy for malignant brain tumors

SI Miyatake, S Kawabata, R Hiramatsu… - Neurologia medico …, 2016 - jstage.jst.go.jp
Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on
the nuclear capture and fission reactions that occur when non-radioactive boron-10, which is …

Boron neutron capture therapy: clinical application and research progress

X Cheng, F Li, L Liang - Current Oncology, 2022 - mdpi.com
Boron neutron capture therapy (BNCT) is a binary modality that is used to treat a variety of
malignancies, using neutrons to irradiate boron-10 (10B) nuclei that have entered tumor …

Boron neutron capture therapy at the crossroads-Where do we go from here?

RF Barth, JC Grecula - Applied Radiation and Isotopes, 2020 - Elsevier
As elegant as is the concept upon which Boron Neutron Capture Therapy (BNCT) is based,
unfortunately it has not gained widespread acceptance by the physicians who are treating …

The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review

NB Pepper, W Stummer, HT Eich - Strahlentherapie und Onkologie, 2022 - Springer
Background Glioblastoma is the most common malignant brain tumor in human adults.
Despite several improvements in resective as well as adjuvant therapy over the last …

Evaluation of a Novel Boron-Containing α-d-Mannopyranoside for BNCT

T Tsurubuchi, M Shirakawa, W Kurosawa, K Matsumoto… - Cells, 2020 - mdpi.com
Boron neutron capture therapy (BNCT) is a unique anticancer technology that has
demonstrated its efficacy in numerous phase I/II clinical trials with boronophenylalanine …

Boron neutron capture therapy for malignant brain tumors

SI Miyatake, M Wanibuchi, N Hu, K Ono - Journal of neuro-oncology, 2020 - Springer
Background Boron neutron capture therapy (BNCT) is tumor-selective particle radiation
therapy that depends on the nuclear capture and fission reactions. These reactions occur …

Diagnostic and theranostic technologies used in boron neutron capture therapy–A brief review

P Coghi, T Fazal, NS Hosmane, Y Zhu - Inorganic Chemistry …, 2024 - Elsevier
Boron neutron capture therapy (BNCT) is a highly targeted, selective and effective technique
to cure various types of cancers, with less harms to the healthy cells. In principle, BNCT …